CLINICAL TRIALS PROFILE FOR FABIOR
✉ Email this page to a colleague
All Clinical Trials for FABIOR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02267746 ↗ | A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris | Completed | Actavis Inc. | Phase 3 | 2014-06-01 | The purpose of this study is to compare the safety and therapeutic equivalence of a generic tazarotene foam 0.1% and the reference listed Fabiorâ„¢ (tazarotene foam, 0.1%) in the treatment of acne vulgaris. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FABIOR
Condition Name
Clinical Trial Locations for FABIOR
Trials by Country
Clinical Trial Progress for FABIOR
Clinical Trial Phase
Clinical Trial Sponsors for FABIOR
Sponsor Name